tele.clinic

Resources

Our pharmacy partner.

TeleClinic prescriptions are filled by Rush Pharmacy — a licensed, PCAB-accredited 503A compounding pharmacy.

Our dispensing partner

Rush Pharmacy

All TeleClinic prescriptions are filled by Rush Pharmacy, a licensed 503A compounding pharmacy authorized under Section 503A of the Federal Food, Drug, and Cosmetic Act. Each medication is compounded specifically for you based on your physician's prescription.

Rush Pharmacy is regulated by the FDA and holds active licensure in every state where it ships medication. Pharmacists are licensed and in good standing with their state boards.

Partner pharmacy credentials

License type

503A Compounding Pharmacy

Regulatory body

FDA + State Board of Pharmacy

Accreditation

PCAB (Pharmacy Compounding Accreditation Board)

Quality standard

USP <797> Sterile Compounding Standards

Testing

Third-party potency & sterility testing on each batch

Cold chain

Temperature-controlled shipping for injectables

Quality standards

How we ensure medication quality

USP <797> compliance

All sterile compounding (injectable medications) is performed in ISO Class 5 cleanrooms that meet or exceed USP Chapter <797> standards for sterility, beyond-use dating, and environmental monitoring.

Third-party batch testing

Every batch of compounded medication is tested by an independent, accredited laboratory for potency, purity, sterility, and endotoxin content before release for patient use.

State licensure

Our partner pharmacies hold active licensure in every state where they ship medication. Pharmacists are licensed and in good standing with their state boards.

PCAB accreditation

PCAB accreditation is the gold standard for compounding pharmacy quality. Accredited pharmacies undergo rigorous on-site inspections and must meet more than 200 quality criteria.

Important: Compounded medications are not FDA-approved as finished drug products. FDA approval applies to the active pharmaceutical ingredient, not to the compounded preparation itself. Patients should discuss the benefits and risks of compounded vs. commercially available medications with their physician.